Consent for Cookie Use We use cookies to improve your experience on our websites. You can learn more about what information we collect and how we use it on our Internet Privacy Statement.
Watchful Waiting (Surveillance) for Non-Hodgkin Lymphoma
Treatment Overview
Watchful waiting (surveillance) is a period in the treatment of some types of NHL, Opens dialog in which you are not having treatment. It does not mean that your doctors are giving up or refusing to give you treatment.
During this time, you will:
See your doctor on a regular basis.
Have regular medical tests. These may include blood tests, such as chemistry screens and complete blood counts (CBCs). They may also include imaging tests, such as a CT scan.
Be told which symptoms to report to your doctor immediately.
Watchful waiting may be an option for you if:
Your lymphoma is slow-growing (indolent or low-grade).
You are living comfortably and do not have significant symptoms from your lymphoma.
Information about Watchful Waiting (Surveillance) for Non-Hodgkin Lymphoma
Watchful waiting is often as effective as having treatment for some types of NHL. Some people with slow-growing NHL may live a long time without symptoms.
There do not seem to be any risks involved in watchful waiting for some types of NHL when you are being watched closely by your doctor. If your lymphoma changes, other treatments such as chemotherapy or radiation therapy may be used to control your disease.
Clinical Review Board All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
Clinical Review Board All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.
